Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Preceptis Medical

Request full access

In-office pediatric ear tube placement system

Golden Valley, United StatesFounded 2011Health Tech & Medtech

About Preceptis Medical

Preceptis Medical is a medical technology company that developed the Hummingbird® Tympanostomy Tube System (TTS), an FDA-cleared device for performing pediatric ear tube procedures in an office setting. The company was founded in 2011 by Steve Anderson, who served as CEO, along with a pediatric anesthesiologist, Dr. Michael Loushin, and mechanical engineer Keith Leland. Anderson's personal experience with his son's numerous surgeries inspired the mission to create less invasive options for children and avoid the risks, stress, and costs associated with general anesthesia.

The company's core product, the Hummingbird TTS, enables otolaryngologists (ENTs) to place ear tubes in a single pass using only a topical anesthetic. This patented One-Pass® technology streamlines the traditional multi-step surgical process into a procedure that can be completed in minutes. This approach eliminates the need for an operating room, fasting, and general anesthesia, which is required for the nearly one million children who undergo the procedure annually in the United States. The primary clients for Preceptis Medical are ENT specialists, pediatricians, and healthcare systems like the Mayo Clinic and Phoenix Children's Hospital. The business model focuses on selling the single-use Hummingbird device to these providers, which reduces overall healthcare costs significantly compared to traditional surgery.

Headquartered in the Minneapolis area, Preceptis Medical has raised $19.2 million over nine funding rounds to support clinical studies, commercialization, and product development. The Hummingbird device initially received FDA 510(k) clearance in June 2020 for children aged 6-24 months and later received expanded clearance in August 2022 for all children six months and older. In July 2025, Dave Carey was appointed CEO to lead the company's next phase of growth and the full market release of the Hummingbird system.

Source: Dealroom company data

Preceptis Medical in the Golden Valley ecosystem

Live from Dealroom

The Preceptis Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Partisan Management Group
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Preceptis Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Preceptis Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.